vs
IDEAYA Biosciences, Inc.（IDYA）与MARCUS CORP（MCS）财务数据对比。点击上方公司名可切换其他公司
IDEAYA Biosciences, Inc.的季度营收约是MARCUS CORP的1.1倍（$207.8M vs $193.5M），IDEAYA Biosciences, Inc.自由现金流更多（$142.2M vs $26.4M）
IDEAYA Biosciences是一家临床阶段生物技术企业，专注于肿瘤学领域，研发针对基因定义癌症的靶向疗法及合成致死治疗方案，推进多肿瘤类型的候选药物管线开发，与行业伙伴合作提升全球创新癌症治疗方案的可及性。
马库斯公司是一家美国企业，主营商业地产领域相关服务，业务覆盖美国与加拿大，提供商业地产经纪、按揭经纪、行业研究以及咨询服务，首创了由单一经纪公司独家代理房源挂牌的行业模式，目前在美加两国设有超过80家办公室，拥有员工超1800名。
IDYA vs MCS — 直观对比
营收规模更大
IDYA
是对方的1.1倍
$193.5M
自由现金流更多
IDYA
多$115.8M
$26.4M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $207.8M | $193.5M |
| 净利润 | $119.2M | — |
| 毛利率 | — | — |
| 营业利润率 | 52.2% | 0.9% |
| 净利率 | 57.4% | — |
| 营收同比 | — | 2.8% |
| 净利润同比 | 330.1% | — |
| 每股收益（稀释后） | $1.33 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IDYAMCS
| Q4 25 | — | $193.5M | ||
| Q3 25 | $207.8M | $210.2M | ||
| Q2 25 | — | $206.0M | ||
| Q1 25 | — | $148.8M | ||
| Q4 24 | — | $188.3M | ||
| Q3 24 | $0 | $232.7M | ||
| Q2 24 | $0 | $176.0M | ||
| Q1 24 | $0 | $138.5M |
净利润IDYAMCS
| Q4 25 | — | — | ||
| Q3 25 | $119.2M | $16.2M | ||
| Q2 25 | — | $7.3M | ||
| Q1 25 | — | $-16.8M | ||
| Q4 24 | — | $986.0K | ||
| Q3 24 | $-51.8M | $23.3M | ||
| Q2 24 | $-52.8M | $-20.2M | ||
| Q1 24 | $-39.6M | $-11.9M |
营业利润率IDYAMCS
| Q4 25 | — | 0.9% | ||
| Q3 25 | 52.2% | 10.8% | ||
| Q2 25 | — | 6.3% | ||
| Q1 25 | — | -13.7% | ||
| Q4 24 | — | -1.2% | ||
| Q3 24 | — | 14.1% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | -12.0% |
净利率IDYAMCS
| Q4 25 | — | — | ||
| Q3 25 | 57.4% | 7.7% | ||
| Q2 25 | — | 3.6% | ||
| Q1 25 | — | -11.3% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 10.0% | ||
| Q2 24 | — | -11.5% | ||
| Q1 24 | — | -8.6% |
每股收益（稀释后）IDYAMCS
| Q4 25 | — | — | ||
| Q3 25 | $1.33 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.60 | — | ||
| Q2 24 | $-0.68 | — | ||
| Q1 24 | $-0.53 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $786.9M | $23.4M |
| 总债务越低越好 | — | $159.0M |
| 股东权益账面价值 | $1.1B | $457.4M |
| 总资产 | $1.2B | $1.0B |
| 负债/权益比越低杠杆越低 | — | 0.35× |
8季度趋势，按日历期对齐
现金及短期投资IDYAMCS
| Q4 25 | — | $23.4M | ||
| Q3 25 | $786.9M | $7.4M | ||
| Q2 25 | — | $14.9M | ||
| Q1 25 | — | $11.9M | ||
| Q4 24 | — | $40.8M | ||
| Q3 24 | $920.0M | $28.4M | ||
| Q2 24 | $701.7M | $32.8M | ||
| Q1 24 | $698.8M | $17.3M |
总债务IDYAMCS
| Q4 25 | — | $159.0M | ||
| Q3 25 | — | $162.0M | ||
| Q2 25 | — | $179.9M | ||
| Q1 25 | — | $198.9M | ||
| Q4 24 | — | $159.1M | ||
| Q3 24 | — | $173.1M | ||
| Q2 24 | — | $175.7M | ||
| Q1 24 | — | $169.8M |
股东权益IDYAMCS
| Q4 25 | — | $457.4M | ||
| Q3 25 | $1.1B | $454.3M | ||
| Q2 25 | — | $448.4M | ||
| Q1 25 | — | $441.8M | ||
| Q4 24 | — | $464.9M | ||
| Q3 24 | $1.2B | $462.3M | ||
| Q2 24 | $931.7M | $449.4M | ||
| Q1 24 | $935.3M | $459.3M |
总资产IDYAMCS
| Q4 25 | — | $1.0B | ||
| Q3 25 | $1.2B | $1.0B | ||
| Q2 25 | — | $1.0B | ||
| Q1 25 | — | $1.0B | ||
| Q4 24 | — | $1.0B | ||
| Q3 24 | $1.2B | $1.0B | ||
| Q2 24 | $973.7M | $1.1B | ||
| Q1 24 | $961.5M | $1.0B |
负债/权益比IDYAMCS
| Q4 25 | — | 0.35× | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | 0.45× | ||
| Q4 24 | — | 0.34× | ||
| Q3 24 | — | 0.37× | ||
| Q2 24 | — | 0.39× | ||
| Q1 24 | — | 0.37× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $142.2M | $48.8M |
| 自由现金流经营现金流 - 资本支出 | $142.2M | $26.4M |
| 自由现金流率自由现金流/营收 | 68.4% | 13.6% |
| 资本支出强度资本支出/营收 | 0.0% | 11.6% |
| 现金转化率经营现金流/净利润 | 1.19× | — |
| 过去12个月自由现金流最近4个季度 | $13.5M | $989.0K |
8季度趋势，按日历期对齐
经营现金流IDYAMCS
| Q4 25 | — | $48.8M | ||
| Q3 25 | $142.2M | $39.1M | ||
| Q2 25 | — | $31.6M | ||
| Q1 25 | — | $-35.3M | ||
| Q4 24 | — | $52.6M | ||
| Q3 24 | $-49.2M | $30.5M | ||
| Q2 24 | $-32.9M | $36.0M | ||
| Q1 24 | $-43.8M | $-15.1M |
自由现金流IDYAMCS
| Q4 25 | — | $26.4M | ||
| Q3 25 | $142.2M | $18.2M | ||
| Q2 25 | — | $14.7M | ||
| Q1 25 | — | $-58.3M | ||
| Q4 24 | — | $27.1M | ||
| Q3 24 | $-49.7M | $12.0M | ||
| Q2 24 | $-33.9M | $16.1M | ||
| Q1 24 | $-45.1M | $-30.5M |
自由现金流率IDYAMCS
| Q4 25 | — | 13.6% | ||
| Q3 25 | 68.4% | 8.7% | ||
| Q2 25 | — | 7.1% | ||
| Q1 25 | — | -39.2% | ||
| Q4 24 | — | 14.4% | ||
| Q3 24 | — | 5.2% | ||
| Q2 24 | — | 9.2% | ||
| Q1 24 | — | -22.0% |
资本支出强度IDYAMCS
| Q4 25 | — | 11.6% | ||
| Q3 25 | 0.0% | 9.9% | ||
| Q2 25 | — | 8.2% | ||
| Q1 25 | — | 15.5% | ||
| Q4 24 | — | 13.5% | ||
| Q3 24 | — | 7.9% | ||
| Q2 24 | — | 11.3% | ||
| Q1 24 | — | 11.1% |
现金转化率IDYAMCS
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | 2.41× | ||
| Q2 25 | — | 4.32× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 53.31× | ||
| Q3 24 | — | 1.31× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IDYA
暂无分部数据
MCS
| Theatres | $123.1M | 64% |
| Concessions | $51.0M | 26% |
| Food And Beverage | $21.2M | 11% |
